Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: A study on long-term patient outcome with risk stratification

Asian Journal of Andrology

Volumn 11, Issue 3, 2009, Pages 283-290

  Takizawa, Itsuhiro ^a   Hara, Noboru ^a   Nishiyama, Tsutomu ^a   Kaneko, Masaaki ^a   Hoshii, Tatsuhiko ^a   Tsuchida, Emiko ^a   Takahashi, Kota ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MALE; OUTCOME ASSESSMENT; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RISK ASSESSMENT; RISK FACTOR; SHORT FORM 36; AGED; DISEASE FREE SURVIVAL; FOLLOW UP; HEALTH STATUS; METHODOLOGY; MIDDLE AGED; PROSTATE TUMOR; RADIOTHERAPY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 69249212417     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2009.10     Document Type: Article

References (26)

1. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, et al. Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008; 148: 435-48.
2. Potters L, Klein EA, Kattan MW, Reddy CA, Ciezki JP, et al. Monotherapy for stage T1-T2 prostate cancer: Radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 2004; 71: 29-33.
3. Sommers BD, Beard CJ, D'Amico AV, Dahl D, Kaplan I, et al. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer. Cancer 2007; 110: 2210-7.
4. Scherr D, Swindle PW, Scardino PT. National comprehensive cancer network. National comprehensive cancer network guidelines for the management of prostate cancer. Urology 2003; 61: 14-24.
5. Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 2002; 20: 557-66.
6. Davis JW, Kuban DA, Lynch DF, Schellhammer PF. Quality of life after treatment for localized prostate cancer: Differences based on treatment modality. J Urol 2001; 166: 947-52.
7. Namiki S, Tochigi T, Kuwahara M, Ioritani N, Terai A, et al. Health related quality of life in Japanese men after radical prostatectomy or radiation therapy for localized prostate cancer. Int J Urol 2004; 11: 619-27.
8. Van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen-Van De Kaa CA. The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system. BJU Int 2008; 102: 438-41.
9. Walsh PC. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: A structured debate. J Urol 2000; 163: 1802-7.
10. Soloway MS, Pareek K, Sharifi R, Wajsman Z, McLeod D, et al. Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results. J Urol 2002; 167: 112-6.
11. Hurtado-coll A, Goldenberg SL, Klotz L, Gleave ME. Preoperative neoadjuvant androgen withdrawal therapy in prostate cancer: The Canadian experience. Urology 2002; 60: 45-51.
12. Boccon-Gibod L, Djavan WB, Hammerer P, Hoeltl W, Kattan MW, et al. Management of prostate-specific antigen relapse in prostate cancer: A European Consensus. Int J Clin Pract 2004; 58: 382-90.
13. Consensus statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997; 37: 1035-41.
14. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care1992; 30: 473-83.
15. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, et al. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med Care 1998; 36: 1002-12.
16. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 1998; 51: 1037-44.
17. Kakehi Y, Kamoto T, Ogawa O, Arai Y, Litwin MS, et al. Development of Japanese version of the UCLA Prostate Cancer Index: A pilot validation study. Int J Clin Oncol 2002; 7: 306-11.
18. Saito T, Kitamura Y, Komatsubara S, Matsumoto Y, Sugita T, et al. Outcomes of locally advanced prostate cancer: A single institution study of 209 patients in Japan. Asian J Androl 2006; 8: 555-61.
19. Penson DF, Feng Z, Kuniyuki A, McClerran D, Albertsen PC, et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 2003; 21: 1147-54.
20. Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, et al Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study. J Natl Cancer Inst 2004; 96: 1358-67.
21. Penson DF. Quality of life after therapy for localized prostate cancer. Cancer J 2007; 13: 318-26.
22. Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, et al. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 2007; 177: 2151-6.
23. McCammon KA, Kolm P, Main B, Schellhammer PF. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 1999; 54: 509-16.
24. Litwin MS, Gore JL, Kwan L, Brandeis JM, Lee SP, et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007; 109: 2239-47.
25. Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL. Quality of life and treatment outcomes: Prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer 1997; 79: 1977-86.
26. Kang SH, Kim JW, Bae JH, Park HS, Moon DG, et al. Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: Quality of life in high-risk prostate cancer patients. Asian J Androl 2006; 8: 629-36.